Coste-efectividad de irbesartan en pacientes hipertensos con nefropatía diabética tipo II: una perspectiva española
F. DE ALVARO , A. J. PALMER , L. ANNEMANS , S. ROZE , M. LAMOTTE , R. A. RODBY
Leído
7173
Vecesse ha leído el artículo
545
Total PDF
6628
Total HTML
Información del artículo
ISSN: 02116995Idioma original: Español
Datos actualizados diariamente
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 6 | 71 | 0 | 71 |
| 2025 5 | 126 | 0 | 126 |
| 2025 4 | 96 | 0 | 96 |
| 2025 3 | 131 | 0 | 131 |
| 2025 2 | 121 | 0 | 121 |
| 2025 1 | 94 | 0 | 94 |
| 2024 12 | 67 | 0 | 67 |
| 2024 11 | 78 | 0 | 78 |
| 2024 10 | 84 | 0 | 84 |
| 2024 9 | 93 | 0 | 93 |
| 2024 8 | 84 | 0 | 84 |
| 2024 7 | 57 | 0 | 57 |
| 2024 6 | 71 | 0 | 71 |
| 2024 5 | 69 | 0 | 69 |
| 2024 4 | 65 | 0 | 65 |
| 2024 3 | 48 | 1 | 49 |
| 2024 2 | 67 | 6 | 73 |
| 2024 1 | 45 | 6 | 51 |
| 2023 12 | 55 | 10 | 65 |
| 2023 11 | 59 | 12 | 71 |
| 2023 10 | 68 | 9 | 77 |
| 2023 9 | 98 | 14 | 112 |
| 2023 8 | 63 | 6 | 69 |
| 2023 7 | 51 | 5 | 56 |
| 2023 6 | 73 | 6 | 79 |
| 2023 5 | 53 | 11 | 64 |
| 2023 4 | 36 | 1 | 37 |
| 2023 3 | 63 | 4 | 67 |
| 2023 2 | 48 | 4 | 52 |
| 2022 1 | 62 | 1 | 63 |
| 2022 12 | 45 | 8 | 53 |
| 2022 11 | 42 | 2 | 44 |
| 2022 10 | 72 | 3 | 75 |
| 2022 9 | 52 | 3 | 55 |
| 2022 8 | 33 | 0 | 33 |
| 2022 7 | 54 | 4 | 58 |
| 2022 6 | 35 | 4 | 39 |
| 2022 5 | 64 | 3 | 67 |
| 2022 4 | 52 | 6 | 58 |
| 2022 3 | 35 | 5 | 40 |
| 2022 2 | 48 | 1 | 49 |
| 2021 1 | 45 | 5 | 50 |
| 2021 12 | 45 | 4 | 49 |
| 2021 11 | 47 | 1 | 48 |
| 2021 10 | 39 | 2 | 41 |
| 2021 9 | 43 | 5 | 48 |
| 2021 8 | 41 | 2 | 43 |
| 2021 7 | 39 | 5 | 44 |
| 2021 6 | 36 | 4 | 40 |
| 2021 5 | 51 | 1 | 52 |
| 2021 4 | 98 | 27 | 125 |
| 2021 3 | 28 | 1 | 29 |
| 2021 2 | 66 | 3 | 69 |
| 2020 1 | 32 | 11 | 43 |
| 2020 12 | 46 | 4 | 50 |
| 2020 11 | 44 | 5 | 49 |
| 2020 10 | 35 | 7 | 42 |
| 2020 9 | 51 | 12 | 63 |
| 2020 8 | 43 | 7 | 50 |
| 2020 7 | 69 | 7 | 76 |
| 2020 6 | 40 | 10 | 50 |
| 2020 5 | 102 | 10 | 112 |
| 2020 4 | 77 | 10 | 87 |
| 2020 3 | 86 | 10 | 96 |
| 2020 2 | 105 | 8 | 113 |
| 2020 1 | 80 | 10 | 90 |
| 2019 12 | 39 | 3 | 42 |
| 2019 11 | 36 | 11 | 47 |
| 2019 10 | 47 | 8 | 55 |
| 2019 9 | 44 | 2 | 46 |
| 2019 8 | 43 | 5 | 48 |
| 2019 7 | 27 | 7 | 34 |
| 2019 6 | 33 | 1 | 34 |
| 2019 5 | 31 | 5 | 36 |
| 2019 4 | 45 | 2 | 47 |
| 2019 3 | 18 | 1 | 19 |
| 2019 2 | 19 | 4 | 23 |
| 2019 1 | 28 | 4 | 32 |
| 2018 12 | 46 | 12 | 58 |
| 2018 11 | 26 | 9 | 35 |
| 2018 10 | 23 | 7 | 30 |
| 2018 9 | 30 | 3 | 33 |
| 2018 8 | 38 | 12 | 50 |
| 2018 7 | 15 | 6 | 21 |
| 2018 6 | 35 | 10 | 45 |
| 2018 5 | 40 | 8 | 48 |
| 2018 4 | 26 | 3 | 29 |
| 2018 3 | 31 | 6 | 37 |
| 2018 2 | 22 | 5 | 27 |
| 2018 1 | 28 | 5 | 33 |
| 2017 12 | 25 | 8 | 33 |
| 2017 11 | 34 | 8 | 42 |
| 2017 10 | 37 | 9 | 46 |
| 2017 9 | 29 | 6 | 35 |
| 2017 8 | 23 | 4 | 27 |
| 2017 7 | 42 | 7 | 49 |
| 2017 6 | 38 | 6 | 44 |
| 2017 5 | 52 | 8 | 60 |
| 2017 4 | 55 | 3 | 58 |
| 2017 3 | 27 | 3 | 30 |
| 2017 2 | 24 | 7 | 31 |
| 2016 1 | 13 | 3 | 16 |
| 2016 12 | 19 | 3 | 22 |
| 2016 11 | 35 | 11 | 46 |
| 2016 10 | 48 | 10 | 58 |
| 2016 9 | 74 | 4 | 78 |
| 2016 8 | 124 | 0 | 124 |
| 2016 7 | 95 | 0 | 95 |
| 2016 6 | 79 | 0 | 79 |
| 2016 5 | 72 | 0 | 72 |
| 2016 4 | 64 | 0 | 64 |
| 2016 3 | 60 | 0 | 60 |
| 2016 2 | 77 | 0 | 77 |
| 2015 1 | 69 | 0 | 69 |
| 2015 12 | 68 | 0 | 68 |
| 2015 11 | 78 | 0 | 78 |
| 2015 10 | 65 | 0 | 65 |
| 2015 9 | 69 | 0 | 69 |
| 2015 8 | 46 | 0 | 46 |
| 2015 7 | 74 | 0 | 74 |
| 2015 6 | 38 | 0 | 38 |
| 2015 5 | 77 | 0 | 77 |
| 2015 4 | 11 | 0 | 11 |
| 2015 2 | 1 | 0 | 1 |
Mostrar todo
